CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-07 | Andres Juan | Exercise or conversion | +2,000 | $20.93 | $42K | 14,803 |
| 2022-12-07 | Andres Juan | Sale | −2,000 | $172.16 | $344K | 12,803 |
| 2022-12-07 | Andres Juan | Exercise or conversion · Stock Option (Right to Buy) | −2,000 | 209,025 | ||
| 2022-12-07 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2022-12-07 | Bancel Stephane Chief Executive Officer | Sale | −443 | $175.26 | $78K | 5,451,503 |
| 2022-12-07 | Bancel Stephane Chief Executive Officer | Sale | −7,613 | $176.56 | $1.3M | 5,443,890 |
| 2022-12-07 | Bancel Stephane Chief Executive Officer | Sale | −15,826 | $177.30 | $2.8M | 5,428,064 |
| 2022-12-07 | Bancel Stephane Chief Executive Officer | Sale | −4,961 | $178.23 | $884K | 5,423,103 |
| 2022-12-07 | Bancel Stephane Chief Executive Officer | Sale | −10,557 | $179.49 | $1.9M | 5,412,546 |
| 2022-12-07 | Bancel Stephane Chief Executive Officer | Sale | −600 | $180.11 | $108K | 5,411,946 |
| 2022-12-07 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 2,307,155 | ||
| 2022-12-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion | +1,139 | 5,262 | ||
| 2022-12-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units | −1,139 | 11,386 | ||
| 2022-12-07 | AFEYAN NOUBAR Director | Sale | −10,000 | $172.16 | $1.7M | 2,297,209 |
Page 66 of 66 · 1,314 trades